|Articles|October 28, 2014

Kimberly-Clark Sterilization Wrap Receives FDA Clearance for All Standard Sterilization Methods

Kimberly-Clark Health Care, soon to be Halyard Health, announces that it is the first and only manufacturer to receive 510(k) clearance from the Food and Drug Administration (FDA) for use of their sterilization wrap portfolio with all standard sterilization modalities.

The KIMGUARD ONE-STEP and QUICK CHECK family of sterilization wrap is now the most validated sterilization wrap on the U.S. market, with comprehensive FDA clearance for use with all of the following sterilization modalities:

• Low Temperature
STERRAD® Sterilization Systems
STERRAD® 100NX
STERRAD® NX
STERRAD® 100S
STERRAD® 200
STARRAD® 50

STERIS® Sterilization Systems
STERIS® V-PRO 1
STERIS® V-PRO 1 Plus
STERIS® V-PRO max

• Pre-vacuum Steam
• Ethylene Oxide (EO)
• Gravity Steam

“Providing innovation in sterilization technology has been a longtime priority at Kimberly-Clark Health Care and we will continue to invest in innovation as we transition to Halyard Health,” says Lon Taylor, marketing director of surgical and infection prevention for Kimberly-Clark Health Care. “Securing FDA clearance for use of our market-leading sterilization wrap with each and every sterilization modality supports our ongoing mission to help clinicians prevent infections and protect patients.”       

The Kimberly-Clark Sterilization Wrap portfolio includes innovations such as QUICK CHECK Wrap, the first dual-color wrap in the U.S. market, and SMART-FOLD, a totally new type of sterilization wrap designed to be three times more tear-resistant and twice as fast to use as conventional wrap.

In November 2014 Kimberly-Clark Health Care will become Halyard Health, an independent medical technology company focused on preventing infection, eliminating pain and speeding recovery.

Source: Kimberly-Clark Corp.


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.